Machete attacks leave children with 'war-zone' injuries, say Leeds trauma staff
On-shift with the Leeds hospital team caring for young knife crime patients in West Yorkshire.
Similar Posts
Norovirus alert: FDA warns of contaminated raw oysters from Mexico
Raw oysters from certain parts of Mexico could be a source of norovirus, the U.S. Food and Drug Administration (FDA) is warning. The agency has advised restaurants and retailers to stop selling and to dispose of oysters harvested from Bahia Salina, Sonora, Mexico — which were shipped by freight carrier Sociedad Acuicola GolPac on Dec….
Ozempic and Wegovy overdose calls have spiked, experts say — what to know about dangerous doses
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Home hospital brings ‘phenomenal’ benefits to patients and providers, study finds
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Cambridge lab grows 'mini-placentas' for pre-eclampsia study
Pre-eclampsia affects millions of women worldwide yet is little understood, say scientists.
Dog attacks: Victims double since pandemic, surgeon says
An NHS consultant surgeon in West Sussex says he is treating dog attack victims every day.
Moderna stock jumps after Oppenheimer upgrade on pipeline potential
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…